Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Dalteparin × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 16 Gastrointestinal 7 Thoracic 4 Sarcoma 3 Plasma cell 3 Lymphoid 2 Gynecologic 2 Genitourinary 2 CNS 2 Tumor-Agnostic 1 Other neoplasm 1 Other hematologic neoplasm 1 Other 1 Myeloid 1 Dermatologic 1 Breast 1

Conditions

Venous Thromboembolism 1 Obesity 1 Neoplasms 1

Interventions

Exercise 25 Metformin 19 Surveys and Questionnaires 15 Methods 12 Early Intervention, Educational 12 Radiotherapy 11 Counseling 11 naloxegol 10 Standard of Care 10 Educational Status 10 Tirzepatide 8 Psychiatric Rehabilitation 8 Nutrition Assessment 8 Diet Therapy 8 Diet 8 Therapeutics 7 Resistance Training 7 Interviews as Topic 7 Cisplatin 7 alvimopan 6 Caloric Restriction 6 semaglutide 5 Radiation 5 Liraglutide 5 Exenatide 5 Diet, Mediterranean 5 Dexamethasone 5 Blood Specimen Collection 5 Bariatric Surgery 5 Specimen Handling 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03297359 2024-01-23

WAVe

Ottawa Hospital Research Institute

Phase 2 Terminated

Classical hematologyOther

Neoplasms, Obesity, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡